Papers
12
Total Citations
202
H-Index
7
About
Dr. Wan Song is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for prostate, kidney, and upper tract cancers. His major contributions focus on refining robotic-assisted procedures to improve patient outcomes, particularly in urinary continence recovery and oncologic control. Dr. Song’s pioneering research using 3 Tesla MRI to measure membranous urethral length has provided critical insights for predicting and enhancing continence after robotic radical prostatectomy, a study that has garnered 52 citations. He has also been at the forefront of single-port robotic surgery, demonstrating its feasibility and safety in prostatectomy with the da Vinci SP system. His comparative studies on robotic versus laparoscopic partial nephrectomy for complex renal tumors (31 citations) and robotic radical nephroureterectomy for upper tract urothelial carcinoma have helped establish best practices and trends in surgical utilization. With over 200 total citations across his most-cited works, Dr. Song’s research directly impacts surgical decision-making, learning curves for novice surgeons, and risk stratification for recurrence, making him a key figure in the evolution of robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10